Decreased FAF2 expression has also been shown to facilitate tau seeding [114], indicating that APOE4-sensitive ERAD proteins could be drivers for a host of AD-associated proteostatic and neuropathologic events. The gene discussed is MAPT; the disease is Alzheimer disease.